- Alcoholic Neuropathy
- Nutritional Peripheral Neuropathies
- Postbariatric Surgery Chronic and Neuropathic Pain
- Methotrexate
- Neurological Disorders Provoked by Neck Movement
- Strachan Syndrome
- Mirtazapine
- Anticholinergic Burden
- OSA and Chronic Pain
- Alcohol and Chronic Pain
- Methadone
- Menopause and Chronic Pain
- Chronic Daily Headache
- Indomethacin Responsive Headaches
- Chronic Pain Assessment
- Lacertus Syndrome
- Caloric Vestibular Stimulation
- Idiopathic Intracranial Hypertension
- Intersection Syndrome
- Neuronopathies
Template:Home grid
From WikiMSK
WELCOME TO WIKIMSK
The New Zealand Musculoskeletal Medicine Wiki
Nau mai, haere mai! This website is a learning resource that is primarily designed for Musculoskeletal Medicine training in New Zealand. It also aims to be useful for GPs, other doctors, and medical students. It is not written for patients but they are welcome to read the articles. Click on a body region on the skeleton or a portal below to get started.
Portals
Regions · Concepts · Procedures · DDX · Cases · EBQs · Links
Trainee Portal · Members Portal · AAMM Portal
Trainee Portal · Members Portal · AAMM Portal
Featured Wiki Article for 1 October 2024
Medicinal Cannabis
The evidence does not support the use of medicinal cannabis in Musculoskeletal Medicine - it is not effective for pain and it may in fact lower pain thresholds. - Read More
New and Updated Articles
- Pain Oriented Sensory Testing
- Sensory Polyneuropathies
- Neuromuscular Disorders Overview
- Nerve Conduction Studies
- Small Fibre Neuropathy
- Alcoholic Neuropathy
- Idiopathic Intracranial Hypertension
- Spontaneous Intracranial Hypotension
- Alcohol and Chronic Pain
- Nutritional Peripheral Neuropathies
- Postbariatric Surgery Chronic and Neuropathic Pain
- Strachan Syndrome
- Obesity and Chronic Pain
- Neurological Disorders Provoked by Neck Movement
- Gait
- Corticosteroids
- Methotrexate
- Myositis
- Mirtazapine
- Anticholinergic Burden
Featured Open Access Journal Article for 1 November 2024
Open-Label Placebo Injection for Chronic Back Pain With Functional Neuroimaging
JAMA Psychiatry
ABSTRACT - In this randomized clinical trial of 101 adults with chronic back pain, an open-label subcutaneous placebo (saline) injection led to significant improvements in pain intensity, mood, and sleep at 1 month posttreatment compared with usual care. The placebo treatment also led to reduced somatomotor activity and increased medial prefrontal activity during evoked back pain and to increased medial prefrontal-brainstem functional connectivity during spontaneous pain.
